Gastrointestinal Stromal Tumors (GSTs) Treatment Report
By www.reliablebusinessinsights.com
Report Details
Report Name
Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size, Status And Forecast 2024-2031 Story
Pages
107
Price
$ 3900
Features
Gastrointestinal Stromal Tumors (GSTs) Treatment Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Companies Covered
Pfizer
Bayer
Novartis
Immunicum
Roche
AB Science
Arog Pharmaceuticals
Boston Biomedical
Sun Pharmaceutical
Natco Pharma